Department of Molecular and Medical Pharmacology,
Department of Urology
Lily Wu has not added Biography.
If you are Lily Wu and would like to personalize this page please email our Author Liaison for assistance.
Optimizing prostate cancer suicide gene therapy using herpes simplex virus thymidine kinase active site variants.
Human gene therapy May, 2002 | Pubmed ID: 11975845
Interrogating androgen receptor function in recurrent prostate cancer.
Cancer research Aug, 2003 | Pubmed ID: 12907631
Integrated, molecular engineering approaches to develop prostate cancer gene therapy.
Current gene therapy Oct, 2003 | Pubmed ID: 14529351
Transcriptionally targeted gene therapy to detect and treat cancer.
Trends in molecular medicine Oct, 2003 | Pubmed ID: 14557054
Micro-PET/CT monitoring of herpes thymidine kinase suicide gene therapy in a prostate cancer xenograft: the advantage of a cell-specific transcriptional targeting approach.
Molecular imaging Oct-Dec, 2005 | Pubmed ID: 16285908
Applications of molecular imaging in cancer gene therapy.
Current gene therapy Dec, 2005 | Pubmed ID: 16457650
Differential biodistribution of adenoviral vector in vivo as monitored by bioluminescence imaging and quantitative polymerase chain reaction.
Human gene therapy Dec, 2006 | Pubmed ID: 17117891
The current state of preclinical prostate cancer animal models.
The Prostate May, 2008 | Pubmed ID: 18213636
Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer.
Nature medicine Aug, 2008 | Pubmed ID: 18622403
Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis.
Cancer research Oct, 2008 | Pubmed ID: 18829538
Non-invasive molecular imaging of prostate cancer lymph node metastasis.
Trends in molecular medicine Jun, 2009 | Pubmed ID: 19482514
Polycomb group protein enhancer of zeste 2 is an oncogene that promotes the neoplastic transformation of a benign prostatic epithelial cell line.
Molecular cancer research : MCR Sep, 2009 | Pubmed ID: 19723877
Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice.
Arteriosclerosis, thrombosis, and vascular biology Feb, 2010 | Pubmed ID: 19926832
Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines.
The Prostate May, 2010 | Pubmed ID: 20087897
Mitogen-activated protein kinase phosphatase-1 deficiency decreases atherosclerosis in apolipoprotein E null mice by reducing monocyte chemoattractant protein-1 levels.
Molecular genetics and metabolism Sep, 2010 | Pubmed ID: 20619710
Androgen-independent molecular imaging vectors to detect castration-resistant and metastatic prostate cancer.
Cancer research Oct, 2011 | Pubmed ID: 21933883
Chapter five--The development of transcription-regulated adenoviral vectors with high cancer-selective imaging capabilities.
Advances in cancer research , 2012 | Pubmed ID: 23021244
CSF1R Signaling Blockade Stanches Tumor-Infiltrating Myeloid Cells and Improves the Efficacy of Radiotherapy in Prostate Cancer.
Cancer research May, 2013 | Pubmed ID: 23418320
Inhibition of CSF-1 receptor improves the antitumor efficacy of adoptive cell transfer immunotherapy.
Cancer research Jan, 2014 | Pubmed ID: 24247719
CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.
Cancer research Mar, 2015 | Pubmed ID: 25736687
Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer.
Cancer research Nov, 2015 | Pubmed ID: 26471360
A PCA3 gene-based transcriptional amplification system targeting primary prostate cancer.
Oncotarget Jan, 2016 | Pubmed ID: 26594800
Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression.
The Prostate Oct, 2016 | Pubmed ID: 27338236
Alternative Splicing of EZH2 pre-mRNA by SF3B3 Contributes to the Tumorigenic Potential of Renal Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 07, 2017 | Pubmed ID: 27879367
Endoglin Is Essential for the Maintenance of Self-Renewal and Chemoresistance in Renal Cancer Stem Cells.
Stem cell reports 08, 2017 | Pubmed ID: 28793246
Androgen-receptor splice variant-7-positive prostate cancer: a novel molecular subtype with markedly worse androgen-deprivation therapy outcomes in newly diagnosed patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 01, 2018 | Pubmed ID: 29076496
Inhibition of TAMs improves the response to docetaxel in castration-resistant prostate cancer.
Endocrine-related cancer 01, 2019 | Pubmed ID: 30400004
Mouse- and patient-derived CAM xenografts for studying metastatic renal cell carcinoma.
The Enzymes , 2019 | Pubmed ID: 31727277
Moe Ishihara*,1,
Junhui Hu*,1,
Xiaoyu Zhang2,
YongHyeon Choi3,
Anthony Wong4,
Celine Cano-Ruiz5,
Rongwei Zhao6,
Ping Tan7,
Jonathan L. Tso1,
Lily Wu1,8
1Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles,
2Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles,
3Department of Bioengineering, Hanyang University,
4Department of Ecology and Evolutionary Biology, University of California, Los Angeles,
5Department of Microbiology, Immunology, and Molecular Genetics, University of California, Los Angeles,
6School of Life Sciences, Beijing Normal University,
7Department of Urology, West China Hospital, Sichuan University,
8Department of Urology, David Geffen School of Medicine, University of California, Los Angeles
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados